Latest KFF Health News Stories
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
Readers and Tweeters Decry Medical Billing Errors, Price-Gouging, and Barriers to Benefits
KHN gives readers a chance to comment on a recent batch of stories.
Muchos estadounidenses han recurrido a la última gran idea para perder peso; ya sean dietas de moda, la obsesión por el fitness, hierbas y píldoras poco fiables o la cirugía bariátrica. Parece que nunca acaban siendo la solución mágica con la que la gente sueña.
Patients Complain Some Obesity Care Startups Offer Pills, and Not Much Else
A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?
Readers and Tweeters Take Positions on Sleep Apnea Treatment
KHN gives readers a chance to comment on a recent batch of stories.
You may have seen the ads that promise weight loss and better health — phone apps, rings, and other devices — by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
La nueva generación de medicamentos para la pérdida de peso es prometedora, pero tiene un precio
Algunos pacientes, según los especialistas en medicina de la obesidad, experimentan una disminución de la presión arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sueño gracias a estos nuevos tratamientos.
New Generation of Weight Loss Medications Offer Promise — But at a Price
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
Índice de masa corporal: una medida errónea del peso que afecta el tratamiento de la obesidad
Los tratamientos actuales para la obesidad y los trastornos alimentarios, y sus costos, muchas veces se basan en esta medida que no está amparada en la ciencia.
BMI: The Mismeasure of Weight and the Mistreatment of Obesity
The human body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.
Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles
KHN gives readers a chance to comment on a recent batch of stories.
Nuevo tratamiento para adelgazar: mucho marketing y resultados discretos
Plenity está aprobado por la FDA como un dispositivo que contiene granos de un hidrogel absorbente de origen vegetal. Cada grano se “infla” hasta 100 veces su tamaño, llenando una cuarta parte del estómago de una persona.
New Weight Loss Treatment Is Marked by Heavy Marketing and Modest Results
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.
Meta de las escuelas de medicina: médicos que no discriminen a pacientes con obesidad
La investigación ha demostrado durante mucho tiempo que es menos probable que los médicos respeten a los pacientes con sobrepeso u obesos, incluso cuando casi las tres cuartas partes de los adultos en los Estados Unidos ahora pertenecen a una de esas categorías.
‘Almost Like Malpractice’: To Shed Bias, Doctors Get Schooled to Look Beyond Obesity
Research has long shown that doctors are less likely to respect patients who are overweight or obese — terms that now apply to nearly three-quarters of adults in the U.S. The Association of American Medical Colleges plans to roll out new diversity, equity, and inclusion standards aimed at teaching doctors, among other things, how to treat patients who are overweight with respect.
Bison Pastrami, Anyone? Preschool Assistant Makes Sure Kids Get to Know Indigenous Foods
Fawn Youngbear-Tibbetts wants youngsters to connect with their Native American culture and eat more nutritious foods.
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Health plans’ coverage of the medication, branded as Wegovy — which has a $1,300-a-month price tag — is not a sure thing.
Readers and Tweeters Grapple With COVID Therapies and Forecasts
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Epidemia de obesidad en los Estados Unidos amenaza la eficacia de una vacuna contra COVID
Otras vacunas han demostrado ser menos efectivas en adultos obesos que en la población general, dejándolos más vulnerables a infecciones y enfermedades.
